ACE2 and COVID-19: Regarding critical pathways related to SARS-CoV-2 infection, progesterone signaling can upregulate ACE2 in endothelial cells, thus implicating the differential response to progesterone via PGR Alu I/D in the clinical outcome of COVID-19 as it shares an intricate connection to the RAAS system [60, 61].